We are live on ! Find out more
CLOV icon

Clover Health Investments

178 hedge funds and large institutions have $293M invested in Clover Health Investments in 2024 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 62 increasing their positions, 33 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

122% more call options, than puts

Call options by funds: $27M | Put options by funds: $12.2M

95% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 20

88% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 33

27% more capital invested

Capital invested by funds: $231M → $293M (+$61.4M)

12% more funds holding

Funds holding: 159178 (+19)

2.43% more ownership

Funds ownership: 20.12%22.55% (+2.4%)

Holders
178
Holders Change
+19
Holders Change %
+11.95%
% of All Funds
2.34%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
39
Increased
62
Reduced
33
Closed
20
Calls
$27M
Puts
$12.2M
Net Calls
+$14.9M
Net Calls Change
+$3.41M
Name Holding Trade Value Shares
Change
Change in
Stake
MWM
101
Mission Wealth Management
California
$80.8K -$14 -4 -0%
Two Sigma Advisers
102
Two Sigma Advisers
New York
$77.8K +$88.3K +24,700 New
BM
103
Belfer Management
New York
$74.3K
ACM
104
ADAR1 Capital Management
Texas
$73.4K +$83.3K +23,300 New
KPWS
105
Kestra Private Wealth Services
Texas
$72.5K +$11.8K +3,300 +17%
RG
106
Rathbones Group
United Kingdom
$72.5K
FPL
107
Fortress Private Ledger
North Carolina
$63.6K +$72.2K +20,200 New
LPL Financial
108
LPL Financial
California
$63.4K +$7.68K +2,149 +12%
BFG
109
Bleakley Financial Group
New Jersey
$63K -$322 -90 -0.4%
SC
110
Steph & Co
Wisconsin
$63K +$17.9K +5,000 +33%
Parallax Volatility Advisers
111
Parallax Volatility Advisers
California
$62.5K +$22.9K +6,408 +48%
Cetera Investment Advisers
112
Cetera Investment Advisers
Illinois
$60.4K +$5K +1,400 +8%
KBC Group
113
KBC Group
Belgium
$59K
Cambridge Investment Research Advisors
114
Cambridge Investment Research Advisors
Iowa
$57K +$168 +47 +0.3%
FFM
115
Forum Financial Management
Illinois
$50.6K
TCM
116
Triumph Capital Management
Colorado
$44.8K +$50.8K +14,218 New
APG
117
Abacus Planning Group
South Carolina
$44.7K
Ohio Public Employees Retirement System (OPERS)
118
Ohio Public Employees Retirement System (OPERS)
Ohio
$42.2K +$7.33K +2,050 +18%
CIAM
119
Caitong International Asset Management
Hong Kong
$41.9K +$47.6K +13,306 New
MTIM
120
Marathon Trading Investment Management
Pennsylvania
$41K -$1.77K -495 -4%
SFWC
121
Strategic Family Wealth Counselors
New Jersey
$38.6K
EC
122
EntryPoint Capital
New York
$38.2K -$32.8K -9,190 -43%
KAS
123
Kestra Advisory Services
Texas
$37.6K +$42.7K +11,943 New
NP
124
NorthRock Partners
Minnesota
$37.6K +$4.61K +1,290 +12%
BCM
125
Bayesian Capital Management
New York
$36.9K -$91.5K -25,600 -69%

CLOV Hedge Fund Activity: Q4 2024 in Review

178 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Clover Health Investments (CLOV) for Q4 2024, worth a combined $293M — up 27% from $231M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new CLOV positions and 20 closed out — a net gain of 19 holders — while 62 added to existing stakes and 33 trimmed.

The largest buyer was Marshall Wace, adding an estimated $8.44M. The largest seller was Renaissance Technologies, cutting an estimated $5.05M.

  • 178 institutional investors held Clover Health Investments (CLOV) as of Q4 2024, up from 159 in Q3 2024.
  • Funds reported $293M of Clover Health Investments stock for Q4 2024, up 27% quarter-over-quarter.
  • 39 funds opened new Clover Health Investments positions in Q4 2024 and 20 closed out, a net change of +19 holders.
  • The largest Clover Health Investments buyer in Q4 2024 was Marshall Wace, an estimated $8.44M added.
  • The largest Clover Health Investments seller in Q4 2024 was Renaissance Technologies, an estimated $5.05M sold.

Based on aggregated 13F filings for Q4 2024.